Mercia Fund Managers
Mercia Asset Management is a specialist asset manager based in the United Kingdom, focused on equity and debt investments to support the growth aspirations of regional businesses. The firm manages multiple funds, including venture capital funds dedicated to early-stage technology companies, particularly in the West Midlands. Mercia aims to provide a complete capital solution by investing across various asset classes, including venture and private equity. It emphasizes backing companies with strong growth potential and proprietary technology. The firm offers initial investments typically ranging from £50,000 to £250,000, with the capacity for follow-on investments up to £1 million per company. Mercia Asset Management also allows private investors to participate in high-growth technology companies through its Growth EIS Fund, benefiting from tax reliefs. Established in 1982, Mercia has established a reputation as a proactive partner for business owners, shareholders, and fund investors, aspiring to deliver superior returns.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in Birmingham
Adapttech
Venture Round in 2022
Founded in 2015, Adapttech is a biomedical company based in Birmingham, UK. It develops smart wearable technologies aimed at improving the quality of life for individuals with physical limitations, particularly those who have experienced lower limb loss. The company's innovative products include the INSIGHT Scanner for creating 3D socket models, the INSIGHT Wearable for real-time bio-data collection, and the INSIGHT App for accessing results anytime.
Adapttech
Venture Round in 2021
Founded in 2015, Adapttech is a biomedical company based in Birmingham, UK. It develops smart wearable technologies aimed at improving the quality of life for individuals with physical limitations, particularly those who have experienced lower limb loss. The company's innovative products include the INSIGHT Scanner for creating 3D socket models, the INSIGHT Wearable for real-time bio-data collection, and the INSIGHT App for accessing results anytime.
Health Centrified
Seed Round in 2017
Health Centrified, a Birmingham, UK-based developer of a communication platform which offers secure digital access to healthcare services.The company intends to use the funds to support the development, evaluation and commercialisation of its software platform.
Adapttech
Seed Round in 2016
Founded in 2015, Adapttech is a biomedical company based in Birmingham, UK. It develops smart wearable technologies aimed at improving the quality of life for individuals with physical limitations, particularly those who have experienced lower limb loss. The company's innovative products include the INSIGHT Scanner for creating 3D socket models, the INSIGHT Wearable for real-time bio-data collection, and the INSIGHT App for accessing results anytime.
Aston EyeTech
Seed Round in 2014
Aston EyeTech is a tech startup developing a range of proprietary hardware and software products for ocular care. It is revolutionizing the Ocular care ecosystem through increased portability, improved accuracy, and lower costs.
The company is a spinout from Aston University’s School of Optometry. Aston EyeTech was founded in 2014 and is based in Birmingham, England.
Celentyx
Seed Round in 2007
Celentyx is a contract research organization specializing in human immunology assays. It provides bespoke assay services to study the effects of small molecules and biological candidates on the human immune system, with capabilities in immuno-oncology, autoimmunity and inflammation, fibrosis, and neuroinflammation. The company uses an immuno-profiling platform to identify therapeutic targets and rapidly analyze drug action on human immune cells, supporting the development and reprofiling of immunotherapies. It offers rapid analysis of drug effects on immune tissues and cells and access to patient and healthy donor samples for high-resolution investigations. Through collaborations with leading research centers, Celentyx enables detailed investigation of immune function in health and disease, aiding researchers and clinicians in understanding mechanisms and accelerating therapeutic discovery and optimization in immunology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.